QSIQuantum-Si incorporated

$212M

Q4 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$400,000

Gross Profit

$178,00044.5% margin

Operating Income

-$28M-6970.8% margin

Net Income

-$22M-5512.0% margin

EPS (Diluted)

$-0.16

QoQ Revenue Growth

+79.4%

Cash Flow

Operating Cash Flow

-$21M

Free Cash Flow

-$21M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$298M

Total Liabilities

$27M

Stockholders' Equity

$272M

Cash & Equivalents

$134M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$400,000	$0	—
Gross Profit	$178,000	$0	—
Operating Income	-$28M	-$39M	+28.2%
Net Income	-$22M	-$33M	+33.5%

Revenue Segments

Product

$593,00095%

Service

$30,0005%

Geographic Segments

Domestic

$698,000100%

QSI Q4 2023 Earnings — Quantum-Si incorporated Revenue & Financial Results | Market Cap Arena